Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NASDAQ:GHSI

Guardion Health Sciences (GHSI) Stock Price, News & Analysis

Guardion Health Sciences logo

About Guardion Health Sciences Stock (NASDAQ:GHSI)

Advanced Chart
Remove Ads

Key Stats

Today's Range
$3.22
$3.29
50-Day Range
$3.22
$3.50
52-Week Range
$3.04
$18.00
Volume
4,700 shs
Average Volume
105,261 shs
Market Capitalization
$4.35 million
P/E Ratio
0.66
Dividend Yield
155.28%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Guardion Health Sciences, Inc., a clinical nutrition company, develops and distributes clinically supported dietary supplements and medical foods in North America, Europe, and internationally. The company offers GlaucoCetin, a dietary supplement to support mitochondrial function with additional antioxidants to help reduce oxidative stress and increase blood flow throughout the body for enhanced eye support and ocular health; and Lumega-Z, a medical food that replenishes and restores the macular protective pigment. It also provides Viactiv Omega Boost Gel Bites, an omega-3 fish oil dietary supplement. The company distributes medical foods products through e-commerce website, guardionhealth.com. Guardion Health Sciences, Inc. was founded in 2009 and is headquartered in Houston, California.

Remove Ads
Receive GHSI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Guardion Health Sciences and its competitors with MarketBeat's FREE daily newsletter.

GHSI Stock News Headlines

Musk’s real agenda in D.C.
In this urgent exposé, you’ll discover… How Elon and Donald Trump are quietly drawing a radical new map of America…
Guardion Health Sciences Inc (GHSI)
See More Headlines

GHSI Stock Analysis - Frequently Asked Questions

Guardion Health Sciences, Inc. (NASDAQ:GHSI) posted its earnings results on Monday, August, 12th. The company reported ($42.00) EPS for the quarter. The company had revenue of $0.26 million for the quarter. Guardion Health Sciences had a negative trailing twelve-month return on equity of 73.69% and a net margin of 22.79%.

Shares of Guardion Health Sciences reverse split on the morning of Sunday, January 8th 2023. The 1-50 reverse split was announced on Sunday, January 8th 2023. The number of shares owned by shareholders was adjusted after the market closes on Sunday, January 8th 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Guardion Health Sciences (GHSI) raised $6 million in an IPO on Friday, April 5th 2019. The company issued 1,500,000 shares at $4.00 per share. WallachBeth Capital and Westpark Capital acted as the underwriters for the IPO.

Based on aggregate information from My MarketBeat watchlists, some other companies that Guardion Health Sciences investors own include NVIDIA (NVDA), Meta Platforms (META), Advanced Micro Devices (AMD), Broadcom (AVGO), Acasti Pharma (ACST), iBio (IBIO) and General Electric (GE).

Company Calendar

Last Earnings
8/12/2019
Today
3/18/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:GHSI
Employees
10
Year Founded
2009

Profitability

Trailing P/E Ratio
0.66
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$160,000.00
Pretax Margin
-20.29%

Debt

Sales & Book Value

Annual Sales
$12.25 million
Cash Flow
$0.14 per share
Price / Cash Flow
23.15
Book Value
$6.39 per share
Price / Book
0.50

Miscellaneous

Free Float
1,332,000
Market Cap
$4.35 million
Optionable
Not Optionable
Beta
0.73

Social Links

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (NASDAQ:GHSI) was last updated on 3/18/2025 by MarketBeat.com Staff
From Our Partners